Mr. Watcharachai Watcharatham Between 7 January 2015 to 24 March 2015, Mr. Watcharachai Watcharatham aided or abetted Mr. Werawat Changyoo by deposit, transfer and conduct financial transaction in Mr

, the Company's total revenues were 172.95 million Baht, a decrease of 745.28 million Baht or 74.63% from the same period last year. The main factor of the decrease revenue came from the transfer of real

helped offset the impact from cancellation of fees for funds transfer via digital channels. Most commercial banks remained cautious in setting aside allowance for impairment loss on loans as loan quality

BS15, shareholder’s loan granted by the Seller on the share transfer completion date and remaining cash on the share transfer date) Shareholding structure after the completion of shares purchase: The

year such as manufacturing (number of factories, total production capacity), acquisition of raw materials or products for sale, number of raw material distributors, proportions of domestic and overseas

, operates the business of manufacturing and distribution of dialysis and medical equipment, later in February 2018, NCLpurchased some shares from a shareholder, making it the major shareholder with 52.80% of

overview of performance. Unit : Million Baht For the three-months ended 31 March Items Increased (Decreased) 2019 2018 Amount Percentage 1 Revenue from steel tower manufacturing 226.94 177.01 49.93 28.21 2

. Unit : Million Baht For the three-months ended 31 March Items Increased (Decreased) 2018 2017 Amount Percentage 1 Revenue from steel tower manufacturing 177.01 249.73 (72.72) (29.12) 2 Revenue from sale

solution and other medical product manufacturing and trading business. Previously the company held 44% of all shares. Later in February 2018, the company acquired additional shares from one of the

details: Revenues Structure 1. The revenues of manufacturing and distributing of Food Ingredients that are classified into 6 categories as the followings: 1.1 Flavour, Fragrance & Color 1.2 Food Coating 1.3